Kiniksa Pharmaceuticals Class A stock price
키닉사 파머슈티컬스 인터내셔널NASDAQ:KNSA · Nasdaq · Healthcare · sector #13Today's signals · No active technical signal.
Signal details →Kiniksa Pharmaceuticals Class A last closed at $76.31 (+0.69%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is 78.9×. Its overall grade ranks 79 of 741 stocks in Healthcare.
About this company
Kiniksa Pharmaceuticals Class A last closed at $76.31 (+0.69%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 79/741
Valuation grade F
Related stocks
- Regeneron PharmaceuticalsCompetitor
자가면역질환·염증성 질환 치료제 개발에서 경쟁
- Arcalyst (SOBI/Regeneron 관련 시장)Competitor
Kiniksa의 주요 자가염증질환 치료제와 같은 적응증 시장에서 경쟁
- NovartisCompetitor
면역·염증성 질환 치료제 포트폴리오로 경쟁
ETFs holding this stock
Innovator IBD 50 ETF · abrdn Focused U.S. Small Cap Active ETF · Virtus LifeSci Biotech Products ETF
Details →About Kiniksa Pharmaceuticals Class A
- What technical signals does Kiniksa Pharmaceuticals Class A (KNSA) have?
- Kiniksa Pharmaceuticals Class A current technical signals: no active technical signal.
- Is Kiniksa Pharmaceuticals Class A a cup-and-handle pattern?
- No. Kiniksa Pharmaceuticals Class A has no valid Cup signal right now.
- What published figures are available for Kiniksa Pharmaceuticals Class A?
- Market cap: $5.78B. Trailing 12 months PER: 78.9×. Latest quarter PBR: 9.73×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Kiniksa Pharmaceuticals Class A, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.